Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis
Clinical trial NCT02504671 · COMPLETED
Trial details
- NCT number
- NCT02504671
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-23
- Primary completion
- 2017-12-22
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.